Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02905994
Title Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

acute myeloid leukemia

Therapies

Cytarabine + Idarubicin + Volasertib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts general Hospital Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02115 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field